Insider · CIK 0001585697

Hineline Lawrence J.

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001585697

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-11	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−64 sh	$67.12	−$4,295.68	0
2024-03-11	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−29 sh	$67.32	−$1,952.28	0
2024-03-11	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−1,100 sh	$66.54	−$73.2K	29
2024-03-11	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−4,475 sh	$66.47	−$297K	64
2024-03-11	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−4,453 sh	$65.28	−$291K	1,129
2024-03-10	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	−5,582 sh	—	—	5,582
2024-03-10	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	+4,539 sh	$56.73	+$257K	4,539
2024-03-10	Intra-Cellular Therapies, Inc.Stock Option (right to purchase)M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	−4,539 sh	—	—	4,539
2024-03-10	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	+5,582 sh	—	—	5,582
2024-03-07	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−6,618 sh	$66.93	−$443K	0
2024-03-07	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−6,514 sh	$66.26	−$432K	6,618
2024-03-06	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	−13.1K sh	—	—	26,266
2024-03-06	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	+13.1K sh	—	—	13,132
2024-03-01	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	SVP of Finance, CFO	AAward	+26.2K sh	—	—	26,227
2024-02-26	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−288 sh	$70.15	−$20.2K	0
2024-02-26	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−600 sh	$69.81	−$41.9K	0
2024-02-26	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	+5,882 sh	$36.89	+$217K	5,882
2024-02-26	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−6,867 sh	$69.38	−$476K	288
2024-02-26	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−5,282 sh	$69.47	−$367K	600
2024-02-26	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−300 sh	$68.33	−$20.5K	7,155
2024-02-26	Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	−5,882 sh	—	—	0
2024-02-23	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	−7,455 sh	—	—	0
2024-02-23	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	+7,455 sh	—	—	7,455
2024-02-02	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−11K sh	$66.61	−$733K	185
2024-02-02	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−185 sh	$67.35	−$12.5K	0
2024-02-01	Intra-Cellular Therapies, Inc.A Award	SVP of Finance, CFO	AAward	+11.2K sh	—	—	11,183
2023-06-14	Intra-Cellular Therapies, Inc.Stock Option (right to purchase)M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	−40.5K sh	—	—	0
2023-06-14	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−34.2K sh	$63.35	−$2.17M	47,627
2023-06-14	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	+11.8K sh	$36.89	+$434K	77,316
2023-06-14	Intra-Cellular Therapies, Inc.Stock Option (right to purchase)M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	−4,538 sh	—	—	9,078
2023-06-14	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−3,592 sh	$65.01	−$234K	0
2023-06-14	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	+40.5K sh	$53.63	+$2.17M	40,472
2023-06-14	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−44K sh	$64.37	−$2.83M	3,592
2023-06-14	Intra-Cellular Therapies, Inc.Stock Option (right to purchase)M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	−25.1K sh	—	—	0
2023-06-14	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	+4,538 sh	$56.73	+$257K	81,854
2023-06-14	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	+25.1K sh	$23.94	+$600K	65,554
2023-06-14	Intra-Cellular Therapies, Inc.Stock Option (right to purchase)M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	−11.8K sh	—	—	5,882
2023-03-13	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−258 sh	$44.14	−$11.4K	0
2023-03-13	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−5,324 sh	$44.97	−$239K	258
2023-03-10	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−13K sh	$43.17	−$560K	2,700
2023-03-10	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−2,700 sh	$42.52	−$115K	0
2023-03-10	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	−5,582 sh	—	—	11,164
2023-03-10	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	+5,582 sh	—	—	5,582
2023-03-09	Intra-Cellular Therapies, Inc.A Award	SVP of Finance, CFO	AAward	+15.7K sh	—	—	15,663
2023-03-06	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	SVP of Finance, CFO	AAward	+39.4K sh	—	—	39,398
2023-02-24	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−7,455 sh	$47.03	−$351K	0
2023-02-23	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	+7,455 sh	—	—	7,455
2023-02-23	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP of Finance, CFO	MExercise/Conversion	−7,455 sh	—	—	7,455
2023-02-21	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−8,649 sh	$46.54	−$403K	1,794
2023-02-21	Intra-Cellular Therapies, Inc.S Sale	SVP of Finance, CFO	SSale	−800 sh	$47.32	−$37.9K	994

Recent filings

Accepted (ET)
Mar 114
Hineline Lawrence J.0000950170-24-029582
SEC(opens sec.gov)
Mar 84
Hineline Lawrence J.0000950170-24-028819
SEC(opens sec.gov)
Mar 54
Hineline Lawrence J.0000950170-24-026538
SEC(opens sec.gov)
Feb 274
Hineline Lawrence J.0000950170-24-021569
SEC(opens sec.gov)

Companies

Intra-Cellular Therapies, Inc.SVP of Finance, CFO

Address

C/O INTRA-CELLULAR THERAPIES, INC. 3960 BROADWAY

NEW YORK, NY, 10032